24 May 2013
Keywords: merck, co, launches, januvia, uk, sharpe, dohme
Article | 30 April 2007
Merck, Sharpe & Dohme, the UK subsidiary of US drug major Merck & Co, has launched its antidiabetic Januvia (sitagliptin) in its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 April 2007
23 April 2007
23 May 2013
© 2013 thepharmaletter.com